File Download
 
Links for fulltext
(May Require Subscription)
 
Supplementary

Article: Management of obesity in the National Health and Nutrition Examination Survey (NHANES), 2007-2008
  • Basic View
  • Metadata View
  • XML View
TitleManagement of obesity in the National Health and Nutrition Examination Survey (NHANES), 2007-2008
 
AuthorsSamaranayake, NR1
Ong, KL2
Leung, RYH1
Cheung, BMY1
 
Issue Date2012
 
PublisherElsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/annepidem
 
CitationAnnals of Epidemiology, 2012, v. 22 n. 5, p. 349-353 [How to Cite?]
DOI: http://dx.doi.org/10.1016/j.annepidem.2012.01.001
 
AbstractPURPOSE: The prevalence of obesity has been increasing in the United States. We set out to investigate the use of pharmacologic and non-pharmacologic therapy for the treatment of obesity in recent years. METHODS: We included 2630 men and 2702 women who took part in the National Health and Nutrition Examination Survey from 2007 to 2008. We analyzed their demographic and anthropometric data and their weight and drug history. RESULTS: A total of 45.9% of men and 45.0% of women were candidates for treatment (body mass index >/=30 kg/m(2), or >/=27 kg/m(2) with risk factors). Among these participants, 85.1% considered themselves overweight, 90.1% would like to lose weight, 61.9% had dietary changes, 36.5% exercised, 3.7% took nonprescription drugs, and 2.2% took prescription drugs to control weight during the preceding year. During the preceding month, 0.5% and 0.1% of participants were taking phentermine and orlistat, respectively. There were no participants on sibutramine. CONCLUSIONS: Although obesity is highly prevalent, only a small percentage of obese Americans are on anti-obesity medication. The withdrawal of sibutramine would have minimal impact on the general population. There is a need for more lifestyle changes in the majority of obese individuals.
 
ISSN1047-2797
2013 Impact Factor: 2.145
2013 SCImago Journal Rankings: 1.301
 
DOIhttp://dx.doi.org/10.1016/j.annepidem.2012.01.001
 
ISI Accession Number IDWOS:000303783900006
 
ReferencesReferences in Scopus
 
DC FieldValue
dc.contributor.authorSamaranayake, NR
 
dc.contributor.authorOng, KL
 
dc.contributor.authorLeung, RYH
 
dc.contributor.authorCheung, BMY
 
dc.date.accessioned2012-09-05T05:31:50Z
 
dc.date.available2012-09-05T05:31:50Z
 
dc.date.issued2012
 
dc.description.abstractPURPOSE: The prevalence of obesity has been increasing in the United States. We set out to investigate the use of pharmacologic and non-pharmacologic therapy for the treatment of obesity in recent years. METHODS: We included 2630 men and 2702 women who took part in the National Health and Nutrition Examination Survey from 2007 to 2008. We analyzed their demographic and anthropometric data and their weight and drug history. RESULTS: A total of 45.9% of men and 45.0% of women were candidates for treatment (body mass index >/=30 kg/m(2), or >/=27 kg/m(2) with risk factors). Among these participants, 85.1% considered themselves overweight, 90.1% would like to lose weight, 61.9% had dietary changes, 36.5% exercised, 3.7% took nonprescription drugs, and 2.2% took prescription drugs to control weight during the preceding year. During the preceding month, 0.5% and 0.1% of participants were taking phentermine and orlistat, respectively. There were no participants on sibutramine. CONCLUSIONS: Although obesity is highly prevalent, only a small percentage of obese Americans are on anti-obesity medication. The withdrawal of sibutramine would have minimal impact on the general population. There is a need for more lifestyle changes in the majority of obese individuals.
 
dc.description.naturepublished_or_final_version
 
dc.identifier.citationAnnals of Epidemiology, 2012, v. 22 n. 5, p. 349-353 [How to Cite?]
DOI: http://dx.doi.org/10.1016/j.annepidem.2012.01.001
 
dc.identifier.citeulike10318482
 
dc.identifier.doihttp://dx.doi.org/10.1016/j.annepidem.2012.01.001
 
dc.identifier.epage353
 
dc.identifier.hkuros204052
 
dc.identifier.isiWOS:000303783900006
 
dc.identifier.issn1047-2797
2013 Impact Factor: 2.145
2013 SCImago Journal Rankings: 1.301
 
dc.identifier.issue5
 
dc.identifier.pmid22305325
 
dc.identifier.scopuseid_2-s2.0-84860246159
 
dc.identifier.spage349
 
dc.identifier.urihttp://hdl.handle.net/10722/163481
 
dc.identifier.volume22
 
dc.languageeng
 
dc.publisherElsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/annepidem
 
dc.publisher.placeUnited States
 
dc.relation.ispartofAnnals of Epidemiology
 
dc.relation.referencesReferences in Scopus
 
dc.rightsNOTICE: this is the author’s version of a work that was accepted for publication in Annals of Epidemiology. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Annals of Epidemiology, 2012, v. 22 n. 5, p. 349-353. DOI: 10.1016/j.annepidem.2012.01.001
 
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License
 
dc.subject.meshAnti-Obesity Agents - therapeutic use
 
dc.subject.meshCyclobutanes - therapeutic use
 
dc.subject.meshExercise
 
dc.subject.meshNutrition Surveys
 
dc.subject.meshObesity - epidemiology - therapy
 
dc.titleManagement of obesity in the National Health and Nutrition Examination Survey (NHANES), 2007-2008
 
dc.typeArticle
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Samaranayake, NR</contributor.author>
<contributor.author>Ong, KL</contributor.author>
<contributor.author>Leung, RYH</contributor.author>
<contributor.author>Cheung, BMY</contributor.author>
<date.accessioned>2012-09-05T05:31:50Z</date.accessioned>
<date.available>2012-09-05T05:31:50Z</date.available>
<date.issued>2012</date.issued>
<identifier.citation>Annals of Epidemiology, 2012, v. 22 n. 5, p. 349-353</identifier.citation>
<identifier.issn>1047-2797</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/163481</identifier.uri>
<description.abstract>PURPOSE: The prevalence of obesity has been increasing in the United States. We set out to investigate the use of pharmacologic and non-pharmacologic therapy for the treatment of obesity in recent years. METHODS: We included 2630 men and 2702 women who took part in the National Health and Nutrition Examination Survey from 2007 to 2008. We analyzed their demographic and anthropometric data and their weight and drug history. RESULTS: A total of 45.9% of men and 45.0% of women were candidates for treatment (body mass index &gt;/=30 kg/m(2), or &gt;/=27 kg/m(2) with risk factors). Among these participants, 85.1% considered themselves overweight, 90.1% would like to lose weight, 61.9% had dietary changes, 36.5% exercised, 3.7% took nonprescription drugs, and 2.2% took prescription drugs to control weight during the preceding year. During the preceding month, 0.5% and 0.1% of participants were taking phentermine and orlistat, respectively. There were no participants on sibutramine. CONCLUSIONS: Although obesity is highly prevalent, only a small percentage of obese Americans are on anti-obesity medication. The withdrawal of sibutramine would have minimal impact on the general population. There is a need for more lifestyle changes in the majority of obese individuals.</description.abstract>
<language>eng</language>
<publisher>Elsevier Inc. The Journal&apos;s web site is located at http://www.elsevier.com/locate/annepidem</publisher>
<relation.ispartof>Annals of Epidemiology</relation.ispartof>
<rights>NOTICE: this is the author&#8217;s version of a work that was accepted for publication in Annals of Epidemiology. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Annals of Epidemiology, 2012, v. 22 n. 5, p. 349-353. DOI: 10.1016/j.annepidem.2012.01.001</rights>
<rights>Creative Commons: Attribution 3.0 Hong Kong License</rights>
<subject.mesh>Anti-Obesity Agents - therapeutic use</subject.mesh>
<subject.mesh>Cyclobutanes - therapeutic use</subject.mesh>
<subject.mesh>Exercise</subject.mesh>
<subject.mesh>Nutrition Surveys</subject.mesh>
<subject.mesh>Obesity - epidemiology - therapy</subject.mesh>
<title>Management of obesity in the National Health and Nutrition Examination Survey (NHANES), 2007-2008</title>
<type>Article</type>
<description.nature>published_or_final_version</description.nature>
<identifier.doi>10.1016/j.annepidem.2012.01.001</identifier.doi>
<identifier.pmid>22305325</identifier.pmid>
<identifier.scopus>eid_2-s2.0-84860246159</identifier.scopus>
<identifier.hkuros>204052</identifier.hkuros>
<relation.references>http://www.scopus.com/mlt/select.url?eid=2-s2.0-84860246159&amp;selection=ref&amp;src=s&amp;origin=recordpage</relation.references>
<identifier.volume>22</identifier.volume>
<identifier.issue>5</identifier.issue>
<identifier.spage>349</identifier.spage>
<identifier.epage>353</identifier.epage>
<identifier.isi>WOS:000303783900006</identifier.isi>
<publisher.place>United States</publisher.place>
<identifier.citeulike>10318482</identifier.citeulike>
<bitstream.url>http://hub.hku.hk/bitstream/10722/163481/1/Content.pdf</bitstream.url>
</item>
Author Affiliations
  1. The University of Hong Kong
  2. Heart Research Institute Australia